Cokeromyces recurvatus as a human pathogenic fungus: Case report and critical review of the published literature

Pediatric Infectious Disease Journal

Volumn 19, Issue 2, 2000, Pages 155-158

  Ramani, Rama ^a   Newman, Roger ^c   Salkin, Ira F ^a   Li, Karl ^d   Slim, Michel ^d   Arlievsky, Nina ^d   Gedris, Cheryl ^e   Chaturvedi, Vishnu ^a,b  

^a WADSWORTH CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e WESTCHESTER MEDICAL CENTER   (United States)

Author keywords

Abdominal infection; Amphotericin B; Cokeromyces recurvatus

Indexed keywords

AMOXICILLIN; AMPHOTERICIN B LIPID COMPLEX; AMPICILLIN; CILASTATIN; CLAVULANIC ACID; FLUCONAZOLE; IMIPENEM; ITRACONAZOLE; KETOCONAZOLE; SULBACTAM;

ABDOMINAL INFECTION; ANTIFUNGAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CASE REPORT; COKEROMYCES RECURVATUS; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; SCHOOL CHILD;

ABSCESS; ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; CHILD; FEMALE; HUMANS; MALE; MECKEL DIVERTICULUM; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOSES; ZYGOMYCOTA;

EID: 0033952357     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200002000-00014     Document Type: Article

References (13)

1. Kwon-Chung KJ, Bennett JE. Medical mycology. Philadelphia: Lea and Febiger, 1992: 524-59.
2. Rippon JW. Medical mycology: the pathogenic fungi and the pathogenic actinomycetes. 3rd ed. Philadelphia: Saunders, 1988:681-713.
3. Alvarez OA, Maples JA, Tio FO, Lee M. Severe diarrhea due to Cokeromyces recurvatus in a bone marrow transplant recipient. Am J Gastroenterol 1995; 90:1350-1.
4. Axelrod P, Kwon-Chung KJ, Frawley P, Rubin H. Chronic cystitis due to Cokeromyces recurvatus: a case report. J Infect Dis 1987;155:1062-4.
5. Kemna ME, Neri RC, Ali R, Salkin IF. Cokeromyces recurvatus, a mucoraceous zygomycete rarely isolated in clinical laboratories. J Clin Microbiol 1994;32:843-5.
6. McGough DA, Fothergill AW, Rinaldi MG. Cokeromyces recurvatus Poitras, a distinctive zygomycete and potential pathogen: criteria for identification. Clin Microbiol Newsl 1990;12:113-20.
7. Munipalli B, Rinaldi MG, Greenberg SB. Cokeromyces recurvatus isolated from pleural and peritoneal fluid: case report. J Clin Microbiol 1996;34:2601-3.
8. Rippon JW, Dolan CT. Colonization of the vagina by fungi of the genus Mucor. Clin Microbiol Newsl 1979;1:4-5.
9. Tsai TW, Hammond LA, Rinaldi M, et al. Cokeromyces recurvatus infection in a bone marrow transplant recipient. Bone Marrow Transplant 1997;9:301-2.
10. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing for yeasts: approved standard. M27-A. vol 17, no. 9. Villanova, PA: National Committee for Clinical Laboratory Standards, 1997.
11. Kocak R, Tetiker T, Kocak M, Baslamisli F, Zorludemir S, Gonlusen G. Fluconazole in the treatment of three cases of mucormycosis. Eur J Clin Microbiol Infect Dis 1995; 14:559-61.
12. Koszyca B, Ellis D, Toogood I, Byard RW. Fluconazole in the treatment of pulmonary zygomycosis. Mycoses 1995;38:277-80.
13. Towersey L, Wanke B, Estrella RR, Londero AT, Mendonca , AMN, Neves RG. Conidiobolus coronatus infection treated with ketoconazole. Arch Dermatol 1998;124:1392-6.